Sector--
Established Date23/09/2016
Listing Date26/11/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees8
Fiscal Year Ends31/12
Security TypeCommon stock
Office address201 Haskings Way, Suite 230, South San Francisco, CA 94080
Business
IntroductionCERo Therapeutics Holdings, Inc., was incorporated in Delaware on September 23, 2016. CERo is an innovative immunotherapy company driving the development of next-generation engineered T-cell therapies to treat cancer. Its proprietary T-cell engineering approach enables it to integrate certain ideal features of innate and adaptive immunity into a single therapeutic structure designed to mobilize the body's entire immune pool for optimized cancer therapy.
